Metformin use associated with reduced risk of dementia in patients with diabetes: a systematic review and meta-analysis

Manuscript Number: 


Edoardo Aromataris, Susan M. Bellman, Jared M. Campbell, Ian Chapman, Matthew D. Stephenson, Barbora de Courten


Edoardo Aromataris

  • Nothing to Disclose

Susan M. Bellman

  • Nothing to Disclose

Jared M. Campbell

  • Nothing to Disclose

Ian Chapman

  • Lecture Fees:
    Lectures to health professionals (mainly general practitioners) on diabetes and its management. For Astra-Zeneca, Sanofi-Genzyme and Eli Lilly. None for companies making or related to metformin - the topic of this publication

Barbora de Courten

  • Nothing to Disclose

Matthew D. Stephenson

  • Nothing to Disclose